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Psychiatric disordersAbstract Background: Interstitial lung disease (ILD) is a chronic progressive disease resulting in
substantial morbidity and mortality. The cardinal symptom of ILD is dyspnea; however, other pul-
monary and extra-pulmonary symptoms are often present. Depression is a common comorbidity of
many chronic diseases and directly impacts quality of life.
Aim of work: To determine the relationship of dyspnea with selected clinical and psychiatric
variables including functional status and depression in patients with ILD.
Patients and methods: The work included thirty ﬁve clinically and radiologically known cases of
ILD and ten healthy controls, they were subdivided into Group I: Twenty patients without
pulmonary hypertension. Group II: Fifteen patients with pulmonary hypertension. Group III:
Ten healthy controls. All cases subjected to medical history, clinical examination, plain X-ray chest,
HRCT, 6-minute walk test, arterial blood gases, Flow/volume loop , echocardiography, Other
investigations e.g., collagen proﬁle and depression, anxiety, pain, sleep and dyspnea questionnaire.
Results: Among ILD groups: Dyspnea score showed a statistically signiﬁcant positive correla-
tion with psychiatric disorders (depression score, anxiety score, sleep disorders and pain score) while
a statistically signiﬁcant negative correlation with 6MWD, spirometric variables (FEV1 % and






270 H.A. Abu Youssef et al.spirometric and ABG variables) and psychiatric disorders were statistically signiﬁcantly more
affected in ILD group with PHTN than in ILD group without PHTN. There was no statistically
signiﬁcant correlation between psychiatric disorders and both sex and smoking history among
ILD groups.
Conclusion: Dyspnea is common in ILD and is strongly correlated with functional status and
psychiatric disorders. Dyspnea score, functional status and psychiatric disorders are more affected
in ILD with PHTN than in ILD without PHTN. Accordingly, routine screening for mental disor-
ders is recommended for patients with ILD, and should be accompanied by accurate assessment of
patient’s symptoms, particularly in patients with high levels of functional impairment.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Introduction
Interstitial lung disease (ILD) is a diverse group of conditions
that is characterized by inﬂammation and ﬁbrosis of the
pulmonary parenchyma. In general, ILD are chronic and
progressive diseases that result in substantial morbidity and
mortality. The cardinal symptom of ILD is dyspnea; however,
other pulmonary and extra-pulmonary symptoms are often
present [1].
Dyspnea is common in patients with ILD. It is present at
the time of diagnosis in 90% of patients with idiopathic pul-
monary ﬁbrosis (IPF), a common subtype of ILD [2,3].
Importantly, dyspnea severity has been shown to have a
strong correlation with quality of life and mortality in patients
with IPF [4]. Consequently, dyspnea is increasingly recognized
as an important outcome for both prognostic and therapeutic
purposes in ILD. Unfortunately, dyspnea is often refractory to
currently available therapies [3].
While restriction and impaired gas exchange likely inﬂuence
the presence and degree of dyspnea, other factors such as
depression and functional status likely contribute to its severity
[3].
Depression is a common comorbidity of many chronic dis-
eases and directly impacts quality of life [5]. Comorbid depres-
sion has also been shown to predict future development of
clinically relevant outcomes in several chronic diseases, includ-
ing increased mortality [6].
The present study was designed to determine relationship of
dyspnea with selected clinical and psychiatric variables includ-
ing functional status and depression in patients with interstitial
lung disease.
Subjects
The work included thirty ﬁve clinically and radiologically
known cases of ILD and ten healthy controls. They were fur-
ther sub-divided into three groups: Group I: Twenty patients
without PHTN. Group II: Fifteen patients with PHTN. Group
III: Ten healthy controls.
The participants were adult patients >20 years old with
clinical history and radiological ﬁndings on HRCT compatible
with the diagnosis of ILD.
Exacerbation of ILD, patients with superimposed chest
infection (pneumonic inﬁltrate diagnosed by CT) and other
system affection e.g., Cardiac and musculoskeletal system were
excluded.Methods
All were subjected to the following;
Full history taken and Clinical examination, stressing upon:
age, sex, occupational, environmental, smoking and drug his-
tory (especially corticosteroids therapy as their psychiatric
complications are not rare), Plain X-ray of the chest (P-A
view), HRCT chest using general electric (GE) multislice four
detector scanner, Arterial blood gas analysis using a blood gas
analyzer (PHOX PLUS C), other investigations to conﬁrm the
diagnosis e.g., collagen proﬁle.
Pulmonary function tests: Flow/volume loop using body
plethysmography with highly transparent box; Sensor-medics
V max series, 2130 Spirometer, V6200 Autobox, 6200DL.
Spirometry measurements are evaluated by comparison of the
results with appropriate reference value based on age, height,
sex, and race. The Forced vital capacity (FVC), the forced
expiratory volume in the ﬁrst second (FEV1), the ratio of
FEV1 to FVC measured. The presence of an FVC/FEV1 >
0.70 together with FVC < 80% predicated conﬁrm the pres-
ence of restrictive lung disease [7].
Six-minute walk test: Conducted in 30 m long, ﬂat corridor,
and transit-free to avoid turn more often which slows patient’s
pace. Standardized instructions and encouragement were
given, according to ATS guidelines [8]. The walk testing was
discontinued if the patient had thoracic pain, intolerable dysp-
nea, cramps, dizziness, staggering, diaphoresis, pallor, or an
SpO2 < 90% [8].
Echocardiography was performed using (PHILIPS IE 33)
apparatus .It has been used as screening test , stressing on
examination of the right side of the heart, estimating the pul-
monary artery systolic pressure (RVSP). Classiﬁcation of
severity of pulmonary hypertension according to RVSP: Mild:
RVSP 35–44 mmHg, Moderate: RVSP 45–60 mmHg, severe:
RVSP > 60 mmHg [9].
Depression, anxiety, pain, sleep and dyspnea questionnaire:
Degree of shortness of breath with exertion was measured
using ‘‘University of California San Diego Shortness of Breath
Questionnaire (UCSD SOBQ)’’: The SOBQ asks patients to
indicate the severity of shortness of breath experienced on a
six-point scale (0 not at all, to 5 = maximal or unable to do
because of breathlessness) during 21 different activities of daily
living associated with varying levels of exertion. Three addi-
tional questions about limitations due to shortness of breath,
fear of harm from over exertion, and fear of shortness of
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Figure 1 Final diagnosis of ILD groups.
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Scores range from 0 to 120 [10].
Assessment of depressive disorders using questionnaire ‘‘Beck
Depression Inventory (BDI-II)’’, which is a 21-question multi-
ple-choice self-report inventory, each answer being scored on a
scale value of 0–3. The standard cut-offs are as follows: 0–13
Minimal depression, 14–19: Mild depression, 20–28: Moderate
depression, 29–63: Severe depression [11].
Assessment of anxiety disorders using questionnaire ‘‘Beck
Anxiety Inventory (BAI)’’, is a multiple-choice self-report
inventory that is used for measuring the severity of an individ-
ual’s anxiety [12]. The BAI consists of twenty-one questions
about how the subject has been feeling in the last week,
expressed as common symptoms of anxiety (such as numbness
and tingling, sweating not due to heat, and fear of the worst
happening). Each question has the same set of four possible
answer choices, which are arranged in columns and are
answered by marking the appropriate one with a cross, these
are Not at all. (0 points), Mildly: It did not bother me much.
(1 point), Moderately: It was very unpleasant, but I could
stand it. (2 points), Severely: I could barely stand it. (3 points).
Scoring ranges: 0–9: Minimal anxiety, 10–16: Mild anxiety,
17–29: Moderate anxiety, 30–63: Severe anxiety [15].
Pain assessment is done by using ‘‘Visual Analog Scale’’,
which is based on self-report, observational (behavioral) data,
that the patient is asked to refer to degree of his pain on
following chart:
Total scores range from 0 to 10, with a higher score indicating
more severe pain (0 = ’’no pain’’ to 10 = ’’severe pain’’).
Scoring ranges : 0: No pain, 1–3: Mild (nagging, annoying,
interfering little with activities of daily living), 4–6: Moderate
(interferes signiﬁcantly with activities of daily living), 7–10:
Severe (disabling; unable to perform activities of daily living)
[13].
Assessment of sleep disorders using questionnaire ‘‘The Pitts-
burgh Sleep Quality Index (PSQI)’’, which is a 9-question with
a minimum score of 0 (better) and maximum score of 21
(worse) [14]. The patient should be instructed that the ques-
tions were related to his usual sleep habits during the past
month only [14].
Statistical analysis
Statistical presentation and analysis of the results of the pres-
ent study was conducted, using the mean, standard error, Stu-
dent t-test, Chi-square, Linear Correlation Coefﬁcient and
Analysis of variance [ANOVA] tests by SPSS V17. Unpaired
Student’s t-test was used to compare between two groups in
quantitative data. Chi-square the hypothesis that the row
and column variables are independent, without indicating
strength or direction of the relationship. Fisher’s exact test
and Yates’ corrected chi-square are computed for 2 · 2 tables.
Linear Correlation coefﬁcient was used for detection of
correlation between two quantitative variables in one group.
Analysis of variance [ANOVA] tests were carried out.According to the computer program SPSS for Windows
ANOVA test was used for comparison among different times
in the same group in quantitative data. p values less than
0.05 was considered statistically signiﬁcant.
Results
The present study included 35 clinically and radiologically
known cases of ILD and 10 healthy controls. The participants
were subdivided into Group I: 20 patients without PHTN
(12IPF, 1DIP, 1NSIP, 2LIP, 1 sarcoidosis, 1RA, 1sclero-
derma, 1HSP), Group II: 15 patients with ILD with PHTN
(14IPF, 1NSIP) as shown in Fig. 1, Group III: 10 healthy
controls.
Regarding demographic characteristics; there was a statisti-
cally signiﬁcant difference of sex between group I, II, III and
also between group I and II. While there was no statistically
signiﬁcant of both age and smoking history between group I,
II and III as shown in Table 1.
There was no statistically signiﬁcant correlation between
psychiatric disorders and both sex and smoking history as
shown in 2 and 3 among ILD groups.
Regarding the percentage of psychiatric disorders among
the ILD groups: the highest percentage was for pain and sleep
disorders followed by depression then anxiety disorders as
shown in Fig. 2.
Regarding grades of psychiatric disorders among ILD
groups: for depression the highest percentage was for mild
grade followed by moderate then severe grades. For anxiety
the highest percentage was for mild and moderate grades fol-
lowed by severe grade. For pain the highest percentage was
for moderate followed by severe then mild grades as shown
in Table 4.
Among ILD groups: Dyspnea score showed a statistically
signiﬁcant positive correlation with psychiatric disorders while
a statistically signiﬁcant negative correlation with 6MWD, spi-
rometric variables (FEV1 and FVC %) and arterial blood
gases variables (PaO2 and SO2 %) as shown in Table 5.
There was a statistically signiﬁcant difference in clinical
variables (RVSP, 6MWD, spirometric and arterial blood
gas) and psychiatric disorders between ILD groups and con-
trol group while there was no statistically signiﬁcant difference
in age between both groups as shown in Table 6.
Dyspnea score, clinical variables (6MWD, RVSP, spiromet-
ric and arterial blood gases) and psychiatric disorders were sta-
tistically more affected in ILD group with PHTN than in ILD
group without PHTN as shown in Table 7.
Table 1 Demographic characteristics of the studied groups.
Sex Groups
ILD Groups Group III (control) Chi-Square
Group I (without PHTN) Group II (with PHTN)
n % n % N % X2 p-Value
Male 8 40 5 33.33 8 80 I&II&III I&II I&II&III I&II
Female 12 60 10 66.67 2 20 6.16 8.23 0.046* 0.04*
Total 20 100 15 100 10 100
Smoking history
Non smoker 14 70 12 80 7 70 1.55 1.49 0.82 0.78
Current smoker 2 10 1 6.67 2 20
Ex smoker 4 20 2 13.33 1 10
Total 20 100 15 100 10 100
Age (years)
Range 26–73 24–75 33–63 0.58 0.51 0.56 0.72
Mean ± SD 50.00 ± 10.76 46.87 ± 14.81 51.90 ± 8.83
Mean ± SD of ILD groups 48.66 ± 12.55
* p-Value <0.05 statistically signiﬁcant.
Table 2 Correlations of psychiatric disorders with sex among ILD groups.
Male Female t-Test
Mean SD Mean SD t p-Value
Depression score 18.23 11.08 20.86 10.68 0.70 0.49
Anxiety score 14.00 11.37 17.55 10.45 0.94 0.35
Sleep disorders 6.08 3.73 6.50 3.70 0.33 0.75
Pain score 4.21 3.16 4.87 3.30 0.59 0.56
Table 3 Correlations of psychiatric disorders with smoking history among ILD groups.
Non smoker Current smoker Ex smoker ANOVA
Mean SD Mean SD Mean SD F p-Value
Depression score 21.50 10.58 10.33 9.29 17.67 10.84 1.67 0.20
Anxiety score 17.92 10.58 7.67 8.96 13.17 11.27 1.56 0.23
Sleep disorders 6.77 3.70 3.00 2.65 6.17 3.49 1.47 0.24
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Figure 2 Percentage of psychiatric disorders among the ILD
groups.
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The present study demonstrated that the mean ± SD age
among the ILD patients was 48.66 ± 12.55 (range 24–
75 years) with no statistically signiﬁcant difference as shown
in Tables 1 and 7. Similar results were reported by Taghreed
et al. [15] as they found that the mean ± SD age among the
ILD patients was 48.30 ± 12.60 years. While Lindell et al.
[16], Ryerson et al. [17], found that the mean ± SD age among
the ILD patients were 66.19 ± 10.93, 63.90 ± 11.60 years,
respectively.
The present study demonstrated that females were more
common than males among the ILD patients (60% vs 40%
Table 4 Grades of psychiatric disorders among the ILD
groups.
Severe Moderate Mild
% n % n % n
29.2 7 33.3 8 37.5 9 Depression score
30.4 7 34.8 8 34.8 8 Anxiety score
37.03 10 55.56 15 7.41 2 Pain score
Table 5 Correlations of dyspnea score with functional status
and psychiatric disorders among the ILD groups.
Functional status and psychiatric disorders Dyspnea score
R p-Value
6MWD (m) 0.92 0.000*
FEV1/FVC % 0.15 0.384
FEV1 % 0.86 0.000*
FVC % 0.87 0.000*
PaCO2 0.22 0.205
PaO2 0.91 0.000*
SO2 % 0.95 0.000*
Depression score 0.98 <0.001*
Anxiety score 0.99 <0.001*
Sleep disorders 0.94 <0.001*
Pain score 0.96 <0.001*
* p-Value <0.05 statistically signiﬁcant.
Relationship of dyspnea with depression and functional status in interstitial lung disease 273in ILD patients without PHTN and 66.67% vs 33.33% in ILD
patients with PHTN, with a statistical signiﬁcant difference as
shown in Table 1. Taghreed et al. [15] were fully consistent
with this as they found that females were more common than
males among the ILD patients (60% vs 40%, respectively).
While Ryerson et al. [17] and Ryerson et al. [18] found that
males were more common than females among the ILD
patients (56% vs 44%), (56% vs 44%), respectively.
An association between current cigarette smoking and
depression had been found in several studies [19,20], and there
is increased risk of depression in the 6–12 months followingTable 6 Comparison of demographic, clinical and psychiatric varia
















* p-Value <0.05 statistically signiﬁcant.smoking cessation [20]. The present study demonstrated that
there was no correlation in history of smoking between ILD
groups whether the subject was non-smoker, current smoker
or ex-smoker, and also there was no signiﬁcant correlation
between depression among ILD patients and smoking history
as shown in Tables 1 and 3. Ryerson et al. [18] were fully con-
sistent with this, as they found that depression in ILD patients
persists far beyond the time of smoking cessation and the rea-
son for this association is unclear but one possibility is that
there are patient-speciﬁc factors that predispose to both smok-
ing and the development of depressive symptoms.
The present study demonstrated that dyspnea score among
ILD patients showed a statistically signiﬁcant positive correla-
tions with psychiatric disorders as shown in Table 5 which is in
agreement with previous studies [17,18]. While it showed a sta-
tistically signiﬁcant negative correlation with: 6-MWD, spiro-
metric variables (FEV1 and FVC %) and arterial blood gas
variables (PaO2 and SO2 %) as shown in Table 5. This is in
agreement with previous studies [17,21].
The reason for these correlations: this is due to a compli-
cated combination of impairments in ventilation and gas
exchange in patients with restrictive lung diseases and number
of secondary changes such as peripheral muscle, cardiac, nutri-
tional and psychological impairments [22].
Regarding ILD patients with PHTN: The present study
showed that mean ± SD of RVSP in ILD patients without
PHTN was 27.45 ± 2.93 and that of ILD patients with PHTN
was 63.13 ± 13.80 representing a severe degree of pulmonary
hypertension as shown in Table 7. Also (6-MWD), was worse
in ILD patients with PHTN than ILD patients without PHTN
with a statistical signiﬁcant difference between them as shown
in Table 7. Mainguy et al. [23] were fully consistent with this as
they found that 6MWD was worse in patients with pulmonary
hypertension.
The present study demonstrated that depression score, anx-
iety score, pain score and sleep disorders were more prevalent
in ILD patients with PHTN than ILD patients without PHTN
with a statistical signiﬁcant difference between them as shown
in Table 7.
Although no previous studies reported psychiatric disorders
in ILD patients with pulmonary hypertension. Lo¨we et al. [24]
found that 35% of the patients with pulmonary hypertensionbles among the ILD groups and control group.
ILD Groups t-test
SD Mean SD t p-Value
8.82 48.66 12.55 0.76 0.45
1.03 42.74 20.10 4.20 0.00*
73.55 289.34 89.13 9.07 0.00*
3.66 93.11 5.89 5.64 0.00*
5.16 63.94 12.90 4.99 0.00*
2.27 56.40 11.93 7.21 0.00*
0.00 40.40 29.68 4.27 0.00*
0.71 35.37 3.23 3.99 0.00*
3.14 64.63 10.23 6.44 0.00*
1.40 92.77 3.12 3.95 0.00*
1.26 19.89 10.75 5.68 0.00*
0.95 16.23 10.77 4.63 0.00*
0.32 6.34 3.66 5.34 0.00*
0.32 4.63 3.22 4.41 0.00*
Table 7 Comparison of demographic, clinical and psychiatric variables among the ILD patients without PHTN, ILD patients with
PHTN and control group.
Demographic, clinical
and psychiatric variables
ILD Groups Group III (Control) ANOVA Tukey’s test
Group I (without PHTN) Group II (with PHTN)
Mean SD Mean SD Mean SD F p-Value I&II I&III III&II
Age (years) 50.00 10.76 46.87 14.81 51.90 8.82 0.58 0.56 0.72 0.91 0.56
RVSP (mmHg) 27.45 2.93 63.13 13.80 15.80 1.03 122.52 0.00* 0.00* 0.00* 0.00*
6MWD (m) 347.30 67.72 212.07 43.30 569.40 73.55 99.36 0.00* 0.00* 0.00* 0.00*
FEV1/FVC % 93.85 4.31 92.13 7.57 82.00 3.66 16.24 0.00* 0.64 0.00* 0.00*
FEV1 % 70.25 9.90 55.53 11.76 84.89 5.16 27.41 0.00* 0.00* 0.00* 0.00*
FVC % 61.70 9.78 49.33 11.05 83.95 2.27 42.41 0.00* 0.00* 0.00* 0.00*
Dyspnea score 19.85 11.83 67.80 23.27 0.00 0.00 66.43 0.00* 0.00* 0.01* 0.00*
PaCO2 34.52 3.54 36.50 2.42 39.50 0.71 10.78 0.00
* 0.10 0.00* 0.03*
PaO2 71.10 8.42 56.00 4.29 85.90 3.14 67.83 0.00
* 0.00* 0.00* 0.00*
SO2 % 95.10 1.65 89.67 1.35 96.80 1.40 84.07 0.00
* 0.00* 0.02* 0.00*
Depression score 12.45 6.11 29.80 6.75 0.40 1.26 85.33 0.00* 0.00* 0.00* 0.00*
Anxiety score 8.35 4.70 26.73 6.70 0.30 0.95 96.70 0.00* 0.00* 0.00* 0.00*
Sleep disorders 4.50 2.76 8.80 3.30 0.10 0.32 32.50 0.00* 0.00* 0.00* 0.00*
Pain score 2.54 2.30 7.41 1.85 0.10 0.32 51.22 0.00* 0.00* 0.00* 0.00*
* p-Value <0.05 statistically signiﬁcant.
274 H.A. Abu Youssef et al.suffered from mental disorders, with the most common being
major depressive disorder (15.9%) and panic disorder
(10.4%). Omar et al. [25] found that patients with pulmonary
hypertension had an increased prevalence of depression with
poor sleep quality and approximately 50% of patients had
insomnia.
Regarding psychiatric variables and their prevalence and
grading in patients with ILD: The present study demonstrated
that clinically meaningful depression was prevalent in patients
with ILD. Furthermore, the prevalence of depression in our
cohort was 68.57% as shown in Fig. 2. Kunik et al. [26] and
Taghreed et al. [15] were fully consistent with this as they
found that, prevalence of depression in patients with ILD
was (65%) and (73.3%), respectively. While Ryerson et al.
[17] and Ryerson et al. [18] found that, prevalence of depres-
sion in patients with ILD was 23% and 21%, respectively.
Moreover, according to grades of depression the highest
proportion was for mild depression followed by moderate then
severe grades among the ILD group as shown in Table 4.
While Taghreed et al. [15] found that the highest proportion
was for moderate depression (38.7%) followed by mild
(38.1%) then severe grades (23.2%).
The present study demonstrated that depression score, anx-
iety score, pain score and sleep disorders were more prevalent
in females than males among ILD patients with no statistical
signiﬁcant difference as shown in Table 2. Ryerson et al. [18]
were fully consistent as found that depression was more preva-
lent in females than males among the ILD patients.
The present study concluded that dyspnea is common in
ILD patients and is strongly correlated with functional status
and psychiatric disorders. Dyspnea score, functional status
and psychiatric disorders are more affected in ILD patients
with pulmonary hypertension than ILD patients without pul-
monary hypertension. Future longitudinal assessment of the
interactions of dyspnea, depression, and functional status
should investigate if and how changes in these variables are
inter-related and whether treatment of depression and func-
tional status can improve quality of life.Conﬂict of interest
We have no conﬂict of interest.
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